Daratumumab,Talquetamab,Teclistamab,Pomalidomide
Genmab,Janssen
['dara ', 'mmsm']
aa3/ orr in those dara refractory (d2): 76%, while in those bcma exposed (car-t/bite):76% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter